Skip to main content
Equibles
DHR logo

DHR · Danaher Corp · Metrics

Track DHR — free

Use DHR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DHR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$234.85 +2.85 (+1.23%) Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$163.22B
Shares
703.53M
Volume · Oct 28 1.6M Avg daily vol (3M) 4.22M

DHR metrics

113 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$232.00
Market cap
$163.22B

Price action

20 metrics
Price change (1W)
+3.5%
Price change (30D)
+2.1%
Price change (3M)
+16.6%
Price change (6M)
+29.6%
Price change (YTD)
+1.3%
Price change (1Y)
+5.0%
Trailing year
Price change (5Y)
—
52-week high
$242.05
52-week low
$161.91
Change from 52-week high
-4.2%
Change from 52-week low
+43.3%
Annualized volatility
30.2%
Annualized volatility (3M)
28.4%
Beta
0.5
RSI (14D)
60.6
Price vs SMA 50
+6.8%
Price vs SMA 200
+15.3%
Avg volume (3M)
4.22M
Relative volume
0.6
Average dollar volume
$904.26M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
703.53M

Valuation

12 metrics
P / E (TTM)
37.9
Trailing earnings · reciprocal yield 2.6%
PEG ratio
1.0
EV / revenue
7.2×
reciprocal yield 13.9%
EV / EBITDA
—
EV / EBIT
35.3×
reciprocal yield 2.8%
P / sales
6.4×
reciprocal yield 15.7%
P / book
3.0
reciprocal yield 32.9%
FCF yield
3.5%
TTM · current market cap
Buyback yield
0.5%
P / FCF
28.5
reciprocal yield 3.5%
P / operating cash flow
23.8
reciprocal yield 4.2%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
39.8×
reciprocal yield 2.5%
P / E historical average (5Y)
36.7×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
7.0×
reciprocal yield 14.2%
EV / revenue historical average (5Y)
6.9×
reciprocal yield 14.5%
EV / EBIT historical average (3Y)
34.6×
reciprocal yield 2.9%
EV / EBIT historical average (5Y)
32.6×
reciprocal yield 3.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.7%
Trailing 12 months
Payout ratio
23.5%
Shareholder yield
1.2%
Dividend / share (TTM)
$1.52
Dividend growth YoY
+23.6%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-21

Profitability

9 metrics
Gross margin
58.6%
Operating margin
20.4%
Trailing 12 months
Net margin
16.9%
Gross profit (TTM)
$15.01B
Operating profit (TTM)
$5.22B
Net income (TTM)
$4.33B
Trailing 12 months
Diluted EPS (TTM)
$6.12
FCF margin
22.4%
Effective tax rate
11.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$36.11
Gross profit per diluted share (TTM)
$21.16
Operating profit per diluted share (TTM)
$7.36
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$6.11
Operating cash flow per diluted share (TTM)
$9.67
Free cash flow per diluted share (TTM)
$8.08
Capital expenditures per diluted share (TTM)
$1.60
R&D per diluted share (TTM)
$2.35
Stock compensation per diluted share (TTM)
$0.46
Book value per share
$74.32

Growth

11 metrics
Revenue growth YoY
+8.3%
Year over year
Net income growth YoY
+36.0%
Revenue (TTM)
$25.61B
Trailing 12 months
EPS growth YoY
+37.8%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.7%
Revenue CAGR (5Y)
+2.0%
EPS CAGR (3Y)
-19.4%
EPS CAGR (5Y)
+0.6%
FCF CAGR (3Y)
-10.8%
FCF CAGR (5Y)
-0.6%

Quality

14 metrics
Return on equity
8.1%
Return on assets
4.6%
Debt / equity
0.5
Current ratio
1.6
EBITDA (TTM)
—
Free cash flow (TTM)
$5.73B
Quick ratio
1.3
Interest coverage
14.5
Net debt / EBITDA
—
Return on invested capital
6.2%
Trailing 12 months
Net cash
−$20.80B
Latest balance sheet
Cash & equivalents
$5.68B
Total assets
$93.28B
Total debt
$26.48B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.86B
Capital expenditures (TTM)
$1.13B
R&D (TTM)
$1.67B
SG&A (TTM)
$8.12B
Stock compensation (TTM)
$329.00M
R&D / revenue
6.5%
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
2,133
13F filer change QoQ
-62
Institutional ownership
83.0%
Conviction holders (share of 13F filers)
2.3%
Crowding (high-turnover and private-fund holders)
14.0%
Private-fund adviser ownership
13.7%
Active holders' share change QoQ
-1.9%
Holder tenure
18.7
Price vs estimated holder cost
-5.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.0%

Short interest

3 metrics
Short interest
1.2%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$12.74M
Insider-sentiment score
33 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 313616 CUSIP 235851102 13F (30d) 776 filings 712 filers Visit website Investor relations